Cargando…

The Treatment of Peri-Implant Diseases: A New Approach Using HYBENX(®) as a Decontaminant for Implant Surface and Oral Tissues

Background: Peri-implantitis is a pathological condition characterized by an inflammatory process involving soft and hard tissues surrounding dental implants. The management of peri-implant disease has several protocols, among which is the chemical method HYBENX(®). The aim of this study is to demon...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez, Michele Antonio, Passarelli, Pier Carmine, Godino, Emmanuele, Lombardo, Nicolò, Altamura, Francesca Romana, Speranza, Alessandro, Lopez, Andrea, Papi, Piero, Pompa, Giorgio, D’Addona, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147150/
https://www.ncbi.nlm.nih.gov/pubmed/33946370
http://dx.doi.org/10.3390/antibiotics10050512
_version_ 1783697562936541184
author Lopez, Michele Antonio
Passarelli, Pier Carmine
Godino, Emmanuele
Lombardo, Nicolò
Altamura, Francesca Romana
Speranza, Alessandro
Lopez, Andrea
Papi, Piero
Pompa, Giorgio
D’Addona, Antonio
author_facet Lopez, Michele Antonio
Passarelli, Pier Carmine
Godino, Emmanuele
Lombardo, Nicolò
Altamura, Francesca Romana
Speranza, Alessandro
Lopez, Andrea
Papi, Piero
Pompa, Giorgio
D’Addona, Antonio
author_sort Lopez, Michele Antonio
collection PubMed
description Background: Peri-implantitis is a pathological condition characterized by an inflammatory process involving soft and hard tissues surrounding dental implants. The management of peri-implant disease has several protocols, among which is the chemical method HYBENX(®). The aim of this study is to demonstrate the efficacy of HYBENX(®) in the treatment of peri-implantitis and to compare HYBENX(®) with other chemical agents used in the surgical treatment of peri-implantitis. Methods: The present study included a population of ten subjects with severe peri-implantitis. The procedure used in the study involves the application of HYBENX(®) after open-flap debridement. Each patient has been followed for 12 months after a single application of the decontaminant agent. Clinical and radiographical parameters were recorded at baseline, 3 months, and 12 months after treatment completion. Results: At baseline, a mean pocket probing depth (PPD) of 7.3 ± 0.5 mm and a mean clinical attachment level (CAL) of 8.8 ± 0.8 mm was recorded. An average residual PPD of 4.2 ± 0.5 mm and a mean CAL of 5.2 ± 0.8 mm were observed after 1 year. Additionally, the average of bone gain was about 3.4 mm, with a mean marginal bone level (MBL) change from 5.8 mm (baseline) to 2.4 mm (12 months). In total, 90% of the treated implants reached the success rate after the 1-year follow-up. Only in one case out of ten treated implants was resolution of the disease not achieved. Conclusion: Clinical improvements highlight that the procedure of open-flap debridement (OFD) + HYBENX(®) may be considered an effective technique in the treatment of peri-implantitis. From the results obtained, it can be concluded that the use of HYBENX(®) in the surgical treatment of peri-implantitis is promising. Overall, this protocol demands further studies to better understand the role and potential benefits of HYBENX(®) in the treatment of peri-implantitis.
format Online
Article
Text
id pubmed-8147150
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81471502021-05-26 The Treatment of Peri-Implant Diseases: A New Approach Using HYBENX(®) as a Decontaminant for Implant Surface and Oral Tissues Lopez, Michele Antonio Passarelli, Pier Carmine Godino, Emmanuele Lombardo, Nicolò Altamura, Francesca Romana Speranza, Alessandro Lopez, Andrea Papi, Piero Pompa, Giorgio D’Addona, Antonio Antibiotics (Basel) Article Background: Peri-implantitis is a pathological condition characterized by an inflammatory process involving soft and hard tissues surrounding dental implants. The management of peri-implant disease has several protocols, among which is the chemical method HYBENX(®). The aim of this study is to demonstrate the efficacy of HYBENX(®) in the treatment of peri-implantitis and to compare HYBENX(®) with other chemical agents used in the surgical treatment of peri-implantitis. Methods: The present study included a population of ten subjects with severe peri-implantitis. The procedure used in the study involves the application of HYBENX(®) after open-flap debridement. Each patient has been followed for 12 months after a single application of the decontaminant agent. Clinical and radiographical parameters were recorded at baseline, 3 months, and 12 months after treatment completion. Results: At baseline, a mean pocket probing depth (PPD) of 7.3 ± 0.5 mm and a mean clinical attachment level (CAL) of 8.8 ± 0.8 mm was recorded. An average residual PPD of 4.2 ± 0.5 mm and a mean CAL of 5.2 ± 0.8 mm were observed after 1 year. Additionally, the average of bone gain was about 3.4 mm, with a mean marginal bone level (MBL) change from 5.8 mm (baseline) to 2.4 mm (12 months). In total, 90% of the treated implants reached the success rate after the 1-year follow-up. Only in one case out of ten treated implants was resolution of the disease not achieved. Conclusion: Clinical improvements highlight that the procedure of open-flap debridement (OFD) + HYBENX(®) may be considered an effective technique in the treatment of peri-implantitis. From the results obtained, it can be concluded that the use of HYBENX(®) in the surgical treatment of peri-implantitis is promising. Overall, this protocol demands further studies to better understand the role and potential benefits of HYBENX(®) in the treatment of peri-implantitis. MDPI 2021-04-30 /pmc/articles/PMC8147150/ /pubmed/33946370 http://dx.doi.org/10.3390/antibiotics10050512 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lopez, Michele Antonio
Passarelli, Pier Carmine
Godino, Emmanuele
Lombardo, Nicolò
Altamura, Francesca Romana
Speranza, Alessandro
Lopez, Andrea
Papi, Piero
Pompa, Giorgio
D’Addona, Antonio
The Treatment of Peri-Implant Diseases: A New Approach Using HYBENX(®) as a Decontaminant for Implant Surface and Oral Tissues
title The Treatment of Peri-Implant Diseases: A New Approach Using HYBENX(®) as a Decontaminant for Implant Surface and Oral Tissues
title_full The Treatment of Peri-Implant Diseases: A New Approach Using HYBENX(®) as a Decontaminant for Implant Surface and Oral Tissues
title_fullStr The Treatment of Peri-Implant Diseases: A New Approach Using HYBENX(®) as a Decontaminant for Implant Surface and Oral Tissues
title_full_unstemmed The Treatment of Peri-Implant Diseases: A New Approach Using HYBENX(®) as a Decontaminant for Implant Surface and Oral Tissues
title_short The Treatment of Peri-Implant Diseases: A New Approach Using HYBENX(®) as a Decontaminant for Implant Surface and Oral Tissues
title_sort treatment of peri-implant diseases: a new approach using hybenx(®) as a decontaminant for implant surface and oral tissues
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147150/
https://www.ncbi.nlm.nih.gov/pubmed/33946370
http://dx.doi.org/10.3390/antibiotics10050512
work_keys_str_mv AT lopezmicheleantonio thetreatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues
AT passarellipiercarmine thetreatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues
AT godinoemmanuele thetreatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues
AT lombardonicolo thetreatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues
AT altamurafrancescaromana thetreatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues
AT speranzaalessandro thetreatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues
AT lopezandrea thetreatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues
AT papipiero thetreatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues
AT pompagiorgio thetreatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues
AT daddonaantonio thetreatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues
AT lopezmicheleantonio treatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues
AT passarellipiercarmine treatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues
AT godinoemmanuele treatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues
AT lombardonicolo treatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues
AT altamurafrancescaromana treatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues
AT speranzaalessandro treatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues
AT lopezandrea treatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues
AT papipiero treatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues
AT pompagiorgio treatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues
AT daddonaantonio treatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues